Glen Eagle Advisors’s Acadia Healthcare ACHC Stock Holding History

Glen Eagle Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12	Closed	-$364	–	1054
2025 Q1	$364	Hold	12	–	–	﹤0.01%	1012
2024 Q4	$476	Hold	12	–	–	﹤0.01%	1030
2024 Q3	$761	Hold	12	–	–	﹤0.01%	1033
2024 Q2	$810	Buy	+12	New	+$838	﹤0.01%	1028

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Glen Eagle Advisors's ACHC Position: Q2 2025 in Review

Glen Eagle Advisors sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 12 shares — an estimated $364 sold.

Glen Eagle Advisors first reported a position in ACHC in Q2 2024 and held it in 4 quarters. The position peaked at $810 in Q2 2024. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

Glen Eagle Advisors reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
Glen Eagle Advisors sold 12 Acadia Healthcare shares in Q2 2025, an estimated $364.
Glen Eagle Advisors first reported a position in Acadia Healthcare in Q2 2024 and held it in 4 quarters.
Glen Eagle Advisors's Acadia Healthcare position peaked at $810 in Q2 2024.
293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on Glen Eagle Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.